CORTERIA PHARMACEUTICALS
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 1
- Market Cap
- -
CRF2 Agonist for the Treatment of Worsening Heart Failure
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Corteria Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT06815471
Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
Completed
- Conditions
- Heart FailureHeart Decompensation
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Corteria Pharmaceuticals
- Target Recruit Count
- 42
- Registration Number
- NCT05747820
- Locations
- 🇧🇦
Health Institution Medico Laser, Cardiology ward, Banja Luka, Bosnia and Herzegovina
🇦🇲Institute of Cardiology Levon Hovhannisyan, Yerevan, Armenia
🇧🇦Universty Clinical Hospital Mostar, Clinic for Internal diseases with dyalisis center, Clinical ward for cardiology, Mostar, Bosnia and Herzegovina
© Copyright 2025. All Rights Reserved by MedPath